Impact of dose and volume on radiation-induced mucositis

Rays - International Journal of Radiological Sciences

Volumn 30, Issue 2, 2005, Pages 137-144

  Mantini, Giovanna ^a   Manfrida, Stefania ^a   Cellini, Francesco ^a   Giammarino, Daniela ^a   Petrone, Adelina ^a   Vitucci, Pasquale ^a   Cellini, Numa ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Head neck cancer; Radiation mucositis; Radiotherapy

Indexed keywords

CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONSENSUS; DISEASE SEVERITY; DOSE RESPONSE; GASTROINTESTINAL MUCOSA; HEAD AND NECK CANCER; HUMAN; MOUTH ULCER; MUCOSA INFLAMMATION; PRACTICE GUIDELINE; RADIATION DOSE; RADIOTHERAPY; REVIEW; STOMATITIS; THREE DIMENSIONAL IMAGING; TOXICITY TESTING; TUMOR VOLUME;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MOUTH MUCOSA; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; STOMATITIS;

EID: 27744474559     PISSN: 03907740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. FU KK, PAJAK TF, TROTTI A et al. Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
2. CALAIS G, ALFONSI M, BARDET E et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiotherapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086.
3. ELTING L, COOKSLEY C, CHAMBERS M, CANTOR S, MANZULLO E, RUBENSTEIN E. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003; 98: 1531-1539
4. National Institute of Helth (NIH). NIH consensus statement on oral complications of cancer therapies: diagnosis, prevention, and treatment. NIH Consens Statement. 1989; 7: 1-11.
5. EPSTEIN J, EMERTON S, KOLBINSON D et al. Quality of life AND and oral function following radiotherapy for head and neck cancer. Head Neck. 1999; 21: 1-11.
6. TROTTI A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 2000; 47: 1-12.
7. MACIEJEWSKI B, SKLADOWSKI K, PILECKI B et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996; 40: 137-145.
8. DENHAM JW, HAMILTON CS, et al. Acute reaction parameters for human oropharyngeal mucosa. Radiother Oncol 1995; 35: 129-137.
9. REZVAN M, ALCOCK CJ, FOWLER JF, HAYBITTLE JL. Normal tissue reactions in the British Institute of Radiology. Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy. Br J Radiol 1991; 64: 1122-1133.
10. SONIS S, ELTING L, KEEFE D, PETERSON D. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100 Suppl; 1995-2025.
11. GARDEN A. Mucositis: Current Management and investigations. Seminars in Radiation Oncology 2003; 13: 267-273.
12. EPSTEIN J, GORSKY M, GUGLIETTA A, LE N SONIS ST. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer 2000; 89: 2258-2265.
13. DENIS F, GARAUD P, BARDET E et al. Late toxicity results of the GEORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced stage oropharynx carcinoma: comparison of the LENTISOMA, RTOG/ EORTC and NCI-CTC: scoring systems. Int J Radiat Oncol Biol Phys. 2003; 55: 93-98.
14. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva. World Health Organization offset publication No 48, 1979.
15. COX JD, STETZ J, PAJAK TF. Toxicity criteria of the Radiation Therapy Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341-1346, 1995.
16. TROTTI A, BYHARDT R, STETZ J et al. Common Toxicity Criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 13-47.
17. RUBIN P, CONSTINE S, FAJARDO I et al. Overview of late effects of normal tissue (LENT) Scoring Sistem. Int J Radiat Oncol Biol Phys 31: 1041-1042, 1995.
18. Available at.: http://ctep.info.nih.gov/CTC3/ctc.htm. Accessed April 1, 2003.
19. TROTTI A, BELLM LA, EPSTEIN J, FRAME D, FUCHS H et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology 2003; 66: 253-262.
20. VAN DER KOGEL AJ. Radiation response and tolerance of normal tissues. In: Basic clinical radiobiology 3rd ed. 2002; 4: 30-41.
21. KAANDERS JHAM, VAN DER KOGEL AJ, ANN KK. Altered fractionation: limited by mucosal reactions? Radiother Oncol 1999; 50: 247-260.
22. DENHAM JW, WALKER QJ, LAMB DS et al. Mucosal regeneration during radiotherapy. Trans Tasam Radiation Oncol Group (TROG). Radiother Oncol 1996; 41: 10-18.
23. HORIOT JC, BONTEMPS P, VAN DEN BOGAERT W et al. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancer: results of the EORTC 22851 randomized trial. Radiother Oncol 44: 111-121.
24. BENTZEN S, SAUNDERS M, DISCHE S, BOND SJ. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 2001; 60: 123-135.
25. BAUMANN M, BENTZEN S. Clinical manifestations of normal-tissue damages. In: Basic clinical radiobiology 3rd ed. 2002; 105-119.
26. HOPEWELL JW, TROTT KR. Volume effects in radiobiology as applied to radiotherapy. Radiother Oncol 2000; 56: 283-288.
27. PERCH SJ, MACHTAY M, MARKIEWICZ DA, KLIGERMAN MM. Decreased acute toxicity by using midline mucosa sparing blocks during radiation therapy for carcinoma of the oral cavity, oropharynx and nasopharynx. Radiology 1995; 197: 863-866.
28. GREGOIRE V, LEVENDAG P, ANG KK, BERNIER J et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003; 69: 227-236